- Motley Fool•13 hours ago
Fitbit, Ariad Pharmaceuticals, and Trex Company may all be poised to deliver significant returns to investors.
- Investor's Business Daily•yesterday
European, Japanese or specialty pharma could look to acquire Ariad as it rapidly closes in on approval of a lung cancer drug, RBC says.
The Dow Jones Industrial Average's winning streak continued after closing higher for the 18th time in 22 sessions. The S&P 500 also hit a new record high.
ARIA : Summary for ARIAD Pharmaceuticals, Inc. - Yahoo Finance
ARIAD Pharmaceuticals, Inc. (ARIA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||12.83 x 3000|
|Ask||13.14 x 800|
|Day's Range||12.43 - 13.04|
|52 Week Range||4.37 - 14.42|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-74.60|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|